Home
Conditions
Lung Cancer (NSCLC)

Clinical trial condition

Lung Cancer (NSCLC)

Explore clinical trials studying Lung Cancer (NSCLC). Study availability and eligibility vary by location and protocol.

98 public trials 43 recruiting studies

Refine in advanced search Browse all conditions

Lung Cancer (NSCLC) trial results

Not Yet Recruiting

GCC 2545- Improving Post-Radiotherapy Respiratory Function Through Sparing Serial and Parallel Components in the Lung

NCT07679607

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States

View Trial Details

Not Yet Recruiting

Analysis of Different Second Line Treatment in Advanced NSCLC Patients Progressing After 1st Line Immune Checkpoint Inhibitor Therapy

NCT07596524

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Cancer Hospirtal, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

Cancer Hospirtal, Chinese Academy of Medical Sciences, Shenzhen Shenzhen, Guangdong, China

Shanxi Provincial Cancer Hospital Taiyuan, Shanxi, China

View Trial Details

Not Yet Recruiting

Phase 1B Trial of Intratumoral Cisplatin for Stage IV Lung Cancer

NCT07495098

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Osimertinib Plus Capivasertib in NSCLC With PIK3CA/AKT1/PTEN Alterations Following Prior 1L Osimertinib

NCT07486648

Conditions: Advanced Non-Small-Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
Locations: Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

Shanxi Cancer Hospital Taiyuan, Shanxi, China

View Trial Details

Not Yet Recruiting

Immune Response to Immunotherapy in Lung Cancer: Study of Sputum and Blood Samples

NCT07163507

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: university hospital, Tours Tours, France

View Trial Details

Not Yet Recruiting

Phase II Neoadjuvant Study of Garsorasib Followed by Ivonescimab Plus Chemotherapy in Resectable Stage IIA-IIIB KRAS G12C-Mutant NSCLC (GIVEN Study)

NCT07472478

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Tunlametinib Combination Therapy in KRAS-Mutated Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancer

NCT07463677

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

PD-L1 Targeting Peptide Probe for PET Imaging of Solid Tumor

NCT07442292

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +23 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Sublobar Wedge Resection or Stereotactic Radiotherapy Treatment of High-risk Patients With Early-stage Lung Cancer

NCT07432802

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Rigshospitalet Copenhagen, Denmark

Aalborg University Hospital Aalborg, Denmark

Aarhus University Hospital Aarhus N, Denmark

Odense University Hospital Odense, Denmark

View Trial Details

Not Yet Recruiting

Study of Three Endpoints to Assess the Benefit of Rehabilitation in Patients With Advanced Non-small Cell Lung Cancer Controlled After at Least 6 Months of Systemic Treatment

NCT07434947

Conditions: Behavior, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
Locations: CH Métropole Savoie Chambéry, France

Centre Hospitalier Annecy Genevois Annecy, France

CHU Grenoble Alpes Grenoble, France

View Trial Details

Lung Cancer (NSCLC)

Lung Cancer (NSCLC) trial results

Related conditions